INS and metabolic syndrome: HFFD consumption was implicated in the development of MS, which was linked with dyslipidemia, insulin resistance, hepatic oxidative stress, inflammatory condition, and alteration in hepatic expression of genes involved in lipid metabolism and insulin signaling transduction.